Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1965 1
1966 2
1967 1
1968 1
1969 1
1971 1
1982 1
1983 1
1989 1
1995 2
1996 1
1997 3
1998 10
1999 8
2000 4
2001 3
2002 5
2003 4
2004 6
2005 6
2006 8
2007 7
2008 9
2009 3
2010 8
2011 10
2012 17
2013 14
2014 16
2015 10
2016 10
2017 10
2018 7
2019 5
2020 8
2021 7
2022 9
2023 10
2024 20
2025 16
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Results by year

Filters applied: . Clear all
Page 1
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Shitara K, Doi T, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Hosokawa A, Yalçın Ş, Fujitani K, Beretta GD, Cutsem EV, Winkler RE, Makris L, Ilson DH, Tabernero J. Shitara K, et al. Among authors: hosokawa a. Lancet Oncol. 2018 Nov;19(11):1437-1448. doi: 10.1016/S1470-2045(18)30739-3. Epub 2018 Oct 21. Lancet Oncol. 2018. PMID: 30355453 Clinical Trial.
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.
Morizane C, Okusaka T, Mizusawa J, Katayama H, Ueno M, Ikeda M, Ozaka M, Okano N, Sugimori K, Fukutomi A, Hara H, Mizuno N, Yanagimoto H, Wada K, Tobimatsu K, Yane K, Nakamori S, Yamaguchi H, Asagi A, Yukisawa S, Kojima Y, Kawabe K, Kawamoto Y, Sugimoto R, Iwai T, Nakamura K, Miyakawa H, Yamashita T, Hosokawa A, Ioka T, Kato N, Shioji K, Shimizu K, Nakagohri T, Kamata K, Ishii H, Furuse J; members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Morizane C, et al. Among authors: hosokawa a. Ann Oncol. 2019 Dec 1;30(12):1950-1958. doi: 10.1093/annonc/mdz402. Ann Oncol. 2019. PMID: 31566666 Free article. Clinical Trial.
Contribution of germline and somatic mutations to risk of neuromyelitis optica spectrum disorder.
Yata T, Sato G, Ogawa K, Naito T, Sonehara K, Saiki R, Edahiro R, Namba S, Watanabe M, Shirai Y, Yamamoto K, NamKoong H, Nakanishi T, Yamamoto Y, Hosokawa A, Yamamoto M; Japan MS/NMOSD biobank; BioBank Japan Project; Japan COVID-19 Task Force; Oguro-Igashira E, Nii T, Maeda Y, Nakajima K, Nishikawa R, Tanaka H, Nakayamada S, Matsuda K, Nishigori C, Sano S, Kinoshita M, Koike R, Kimura A, Imoto S, Miyano S, Fukunaga K, Mihara M, Shimizu Y, Kawachi I, Miyamoto K, Tanaka Y, Kumanogoh A, Niino M, Nakatsuji Y, Ogawa S, Matsushita T, Kira JI, Mochizuki H, Isobe N, Okuno T, Okada Y. Yata T, et al. Among authors: hosokawa a. Cell Genom. 2025 Mar 12;5(3):100776. doi: 10.1016/j.xgen.2025.100776. Epub 2025 Feb 21. Cell Genom. 2025. PMID: 39986280 Free PMC article.
Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy.
Banks E, Francis V, Lin SJ, Kharfallah F, Fonov V, Lévesque M, Han C, Kulasekaran G, Tuznik M, Bayati A, Al-Khater R, Alkuraya FS, Argyriou L, Babaei M, Bahlo M, Bakhshoodeh B, Barr E, Bartik L, Bassiony M, Bertrand M, Braun D, Buchert R, Budetta M, Cadieux-Dion M, Calame DG, Cope H, Cushing D, Efthymiou S, Elmaksoud MA, El Said HG, Froukh T, Gill HK, Gleeson JG, Gogoll L, Goh ES, Gowda VK, Haack TB, Hashem MO, Hauser S, Hoffman TL, Hogue JS, Hosokawa A, Houlden H, Huang K, Huynh S, Karimiani EG, Kaulfuß S, Korenke GC, Kritzer A, Lee H, Lupski JR, Marco EJ, McWalter K, Minassian A, Minassian BA, Murphy D, Neira-Fresneda J, Northrup H, Nyaga DM, Oehl-Jaschkowitz B, Osmond M, Person R, Pehlivan D, Petree C, Sadleir LG, Saunders C, Schoels L, Shashi V, Spillmann RC, Srinivasan VM, Torbati PN, Tos T; Undiagnosed Diseases Network; Zaki MS, Zhou D, Zweier C, Trempe JF, Durcan TM, Gan-Or Z, Avoli M, Alves C, Varshney GK, Maroofian R, Rudko DA, McPherson PS. Banks E, et al. Among authors: hosokawa a. Nat Commun. 2024 Aug 22;15(1):7239. doi: 10.1038/s41467-024-51310-z. Nat Commun. 2024. PMID: 39174524 Free PMC article.
A multicenter, prospective, observational study of nivolumab readministration for advanced gastric cancer (NIVO RETURNS).
Kodama H, Narita Y, Nakamura M, Takahashi M, Mizukami T, Ando T, Mitani S, Komori A, Hosokawa A, Moriwaki T, Sugiyama K, Taguri M, Orihara S, Kagamu H, Yamaguchi T, Nishikawa H, Muro K. Kodama H, et al. Among authors: hosokawa a. Future Oncol. 2025 Jun;21(14):1753-1759. doi: 10.1080/14796694.2025.2500918. Epub 2025 May 8. Future Oncol. 2025. PMID: 40336472
Optimizing Organ-Preservation Strategies Through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results From the CROC Multi-Institutional Phase 2 Clinical Trial.
Katada C, Yokoyama T, Watanabe A, Hara H, Yoshii T, Fujii H, Yamaguchi H, Nakajima TE, Izawa N, Ando T, Nomura M, Kojima T, Yamashita K, Kawakami S, Ishiyama H, Inoue Y, Sakamoto Y, Sasaki H, Ishikawa H, Hosokawa A, Hamamoto Y, Muto M, Tahara M, Koizumi W. Katada C, et al. Among authors: hosokawa a. Int J Radiat Oncol Biol Phys. 2024 Dec 1;120(5):1353-1362. doi: 10.1016/j.ijrobp.2024.06.019. Epub 2024 Jul 3. Int J Radiat Oncol Biol Phys. 2024. PMID: 38969179 Clinical Trial.
Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301).
Araki T, Sonoda Y, Shimokawa M, Otsuka T, Hayashi K, Honda T, Nakao K, Shibuki T, Nakazawa J, Arima S, Miwa K, Okabe Y, Koga F, Ueda Y, Kubotsu Y, Shimokawa H, Takeshita S, Komori A, Nishikawa K, Otsu S, Hosokawa A, Oda H, Sakai T, Arita S, Kawahira M, Taguchi H, Tsuneyoshi K, Kawaguchi Y, Fujita T, Sakae T, Shirakawa T, Mizuta T, Mitsugi K. Araki T, et al. Among authors: hosokawa a. Sci Rep. 2025 Jan 27;15(1):3427. doi: 10.1038/s41598-025-88005-4. Sci Rep. 2025. PMID: 39870769 Free PMC article.
Chemotherapy-induced Small Bowel Injury.
Hosokawa A, Nishikawa J, Ando T, Sugiyama T. Hosokawa A, et al. Intern Med. 2016;55(8):1023. doi: 10.2169/internalmedicine.55.5800. Epub 2016 Apr 15. Intern Med. 2016. PMID: 27086826 Free article. No abstract available.
Post-partum podocyturia following pre-eclamptic pregnancy.
Furuta I, Zhai T, Umazume T, Ishikawa S, Hosokawa A, Kojima T, Chiba K, Yamada T, Morikawa M, Minakami H. Furuta I, et al. Among authors: hosokawa a. J Obstet Gynaecol Res. 2017 Jun;43(6):1008-1013. doi: 10.1111/jog.13326. J Obstet Gynaecol Res. 2017. PMID: 28621045 Free article.
Analysis of gut microbiome, host genetics, and plasma metabolites reveals gut microbiome-host interactions in the Japanese population.
Tomofuji Y, Kishikawa T, Sonehara K, Maeda Y, Ogawa K, Kawabata S, Oguro-Igashira E, Okuno T, Nii T, Kinoshita M, Takagaki M, Yamamoto K, Arase N, Yagita-Sakamaki M, Hosokawa A, Motooka D, Matsumoto Y, Matsuoka H, Yoshimura M, Ohshima S, Nakamura S, Fujimoto M, Inohara H, Kishima H, Mochizuki H, Takeda K, Kumanogoh A, Okada Y. Tomofuji Y, et al. Among authors: hosokawa a. Cell Rep. 2023 Nov 28;42(11):113324. doi: 10.1016/j.celrep.2023.113324. Epub 2023 Nov 6. Cell Rep. 2023. PMID: 37935197 Free article.
251 results